Drug
Hrs 9190 Under Inhalational Anesthesia
Hrs 9190 Under Inhalational Anesthesia: highest development phase Phase 2, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| HRS-9190; under Inhalational Anesthesia NCT07446309 | Phase 2 | Neuromuscular Blockade |
Latest
No recent events.
Follow Hrs 9190 Under Inhalational Anesthesia on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.